Enlivex Therapeutics Ltd.
ENLV | NASDAQ
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.29
$0.00 (0.00%)
After-hours:
Nov 5, 2026, 6:29 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 57K | n/a | 76K | 81K | 85K | 90K | 36K | 161K | 160K | 188K | 200K | 214K | 212K | 209K | 221K | 192K | 176K | 188K | 150K | 157K | 122K | 117K |
Gross Profit | -57K | n/a | -76K | -81K | -85K | -90K | -36K | -161K | -160K | -188K | -200K | -214K | -212K | -209K | -221K | -192K | -176K | -188K | -150K | -157K | -122K | -117K |
Operating Income | -4.23M | -7.91M | -5.86M | -2.56M | -3.08M | -3.53M | -5.63M | -3.12M | -2.99M | -3.95M | -10.34M | -5.63M | -6.65M | -6.78M | -7.85M | -5.68M | -5.87M | -6.4M | -7.81M | -3.86M | -3.81M | -3.8M |
Interest Income | 23K | n/a | 285K | 352K | 1.21M | 81K | 456K | 517K | n/a | 11K | n/a | n/a | 422 | n/a | n/a | n/a | n/a | n/a | 120K | n/a | 700K | 602K |
Pretax Income | 2.46B | 1.27B | 1.63B | -2.21M | -1.87M | -3.45M | -5.18M | -2.6M | -3.1M | -4.14M | -9.1M | -5.96M | -6.79M | -7.22M | -7.19M | -5.73M | -9.91M | -8.23M | -4.74M | -3.42M | -3.11M | -3.2M |
Net Income | 1.89B | 974.52M | 1.24B | -2.21M | -1.87M | -3.45M | -5.18M | -2.6M | -3.1M | -4.14M | -9.1M | -5.96M | -6.79M | -7.22M | -7.19M | -5.73M | -9.91M | -8.23M | -4.74M | -3.42M | -3.11M | -3.2M |
Selling & General & Admin | 1.31M | 4.6M | 2.72M | 1.07M | 937K | 954K | 1.96M | 771K | 987K | 1.09M | 733K | 1.28M | 1.61M | 1.61M | 1.74M | 1.48M | 1.76M | 1.72M | 2.48M | 1.19M | 1.27M | 1.31M |
Research & Development | 2.92M | 3.31M | 3.03M | 1.48M | 2.14M | 2.55M | 3.42M | 2.35M | 2M | 2.86M | 4.45M | 4.35M | 5.04M | 5.18M | 5.7M | 4.2M | 4.11M | 4.68M | 5.17M | 2.68M | 2.54M | 2.5M |
Other Expenses | -57K | n/a | 35K | -81K | -85K | 29K | 256K | n/a | n/a | 201K | 5.15M | n/a | n/a | n/a | 402K | n/a | n/a | n/a | 167K | n/a | n/a | n/a |
Operating Expenses | 4.18M | 7.91M | 5.79M | 2.48M | 2.99M | 3.53M | 5.63M | 3.12M | 2.99M | 4.15M | 10.34M | 5.63M | 6.65M | 6.78M | 7.85M | 5.68M | 5.87M | 6.4M | 7.81M | 3.86M | 3.81M | 3.8M |
Interest Expense | 1.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 110K | n/a | n/a | 335K | n/a | 435K | -656K | 56K | 4.04M | 1.82M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.23M | 7.91M | 5.86M | 2.56M | 3.08M | 3.53M | 5.63M | 3.12M | 2.99M | 3.95M | 10.34M | 5.63M | 6.65M | 6.78M | 7.85M | 5.68M | 5.87M | 6.4M | 7.81M | 3.86M | 3.81M | 3.8M |
Income Tax Expense | 566.7M | 293.65M | 382.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.03M | 1.12M | 189.36K | 100.19K | 99.4K | 91.23K | 91.23K | 88.66K | 81.44K | 78.03K | 77.49K | 77.49K | 77.44K | 77.15K | 76.76K | 76.63K | 76.56K | 76.54K | 76.3K | 76.3K | 76.28K | 68.67K |
Shares Outstanding (Diluted) | 1.21M | 1.12M | 200.83K | 100.19K | 99.4K | 91.23K | 91.23K | 88.66K | 81.44K | 78.03K | 77.49K | 77.49K | 77.44K | 77.15K | 76.76K | 76.63K | 76.56K | 76.54K | 76.3K | 76.3K | 76.28K | 68.67K |
EPS (Basic) | 1.83K | 868 | 6.56K | -22.08 | -18.72 | -38.40 | -57.60 | -28.80 | -38.40 | -52.80 | -117.60 | -76.80 | -88.80 | -91.20 | -84 | -74.40 | -182.40 | -132 | -62.40 | -45.60 | -40.80 | -45.60 |
EPS (Diluted) | 1.56K | 868 | 6.19K | -22.08 | -18.72 | -38.40 | -57.60 | -28.80 | -38.40 | -52.80 | -117.60 | -76.80 | -88.80 | -91.20 | -84 | -74.40 | -182.40 | -132 | -62.40 | -45.60 | -40.80 | -45.60 |
EBITDA | -4.17M | -7.85M | -5.79M | -2.12M | -2.99M | -3.41M | -5.14M | -2.96M | -2.83M | -3.76M | -5.89M | -5.41M | -6.44M | -6.57M | -7.62M | -5.49M | -5.7M | -6.22M | -7.66M | -3.71M | -3.69M | -3.69M |
EBIT | -4.23M | -7.91M | -5.86M | -2.21M | -3.08M | -3.5M | -5.18M | -3.12M | -2.99M | -3.95M | -6.09M | -5.63M | -6.65M | -6.78M | -7.85M | -5.68M | -5.87M | -6.4M | -7.81M | -3.86M | -3.81M | -3.8M |
Depreciation & Amortization | 60.5K | 60.5K | 76K | 81K | 85K | 90K | 36K | 161K | 160K | 188K | 200K | 214K | 212K | 209K | 221K | 192K | 176K | 188K | 150K | 157K | 122K | 117K |
Add to Watchlist
Select watchlists to add or remove ENLV